Our Pathways Approach

Esperion leverages its understanding of, and experience with, key biological pathways to discover and develop innovative therapies for the treatment of patients with elevated LDL-C. Members of our management  team have a long history of successful drug development endeavors and scientific discoveries. They also have a deep understanding of how the body makes, uses, stores, and eliminates cholesterol and other lipids in the blood and their role in developing therapies for the treatment of patients with elevated LDL-C.

Biological Pathways to Improved Cardiometabolic Health

We are building on our expertise in biological pathways and pioneering novel ways to better regulate lipid metabolism, inflammation, and other cardiometabolic risk factors. We are committed to the development and delivery of new treatments for patients around the world.